Masolin Herbal Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 19 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Satisfied Charges ₹ 0.21 M
- Revenue Growth 49.53%
- Profit Growth -19.18%
- Ebitda 105.10%
- Net Worth -0.86%
- Total Assets -6.28%
About Masolin Herbal
Masolin Herbal Pvt Ltd (MHPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 2006 and has a history of 19 years. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹3.00 M. The company has closed loans amounting to ₹0.21 M, as per Ministry of Corporate Affairs (MCA) records.
Viresh Ghelani, Vaibhav Ghelani, and Devyani Ghelani serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233WB2006PTC107301
-
Company No.
107301
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jan 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Masolin Herbal?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vaibhav Ghelani | Director | 01-Jul-2021 | Current |
Viresh Ghelani | Director | 17-Jan-2006 | Current |
Devyani Ghelani | Director | 01-Jul-2021 | Current |
Financial Performance of Masolin Herbal.
Masolin Herbal Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 49.53% increase. The company also saw a substantial fall in profitability, with a 19.18% decrease in profit. The company's net worth dipped by a decrease of 0.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Masolin Herbal?
In 2023, Masolin Herbal had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0.21 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.30 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
03 Apr 2009 | State Bank Of India | ₹3.00 M | Open |
17 Aug 2009 | State Bank Of India | ₹0.21 M | Satisfied |
How Many Employees Work at Masolin Herbal?
Unlock and access historical data on people associated with Masolin Herbal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Masolin Herbal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Masolin Herbal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.